Tmunity Therapeutics' Series A - III Round

Tmunity Therapeutics raised a round of funding on January 03, 2018.

Tmunity Therapeutics is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit control over T cell activation and …

Articles about Tmunity Therapeutics' Series A - III Round: